FilingReader Intelligence
Aarti Drugs reports Q1 revenue of INR 521bn
July 18, 2025 at 11:29 AM UTC•By FilingReader AI
Aarti Drugs reported standalone revenue of INR 521bn and profit before tax of INR 45bn for the quarter ended June 30, 2025.
Consolidated revenue reached INR 591bn, with consolidated profit before tax of INR 51bn for the same period.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:AARTIDRUGS•Bombay Stock Exchange
News Alerts
Get instant email alerts when Aarti Drugs publishes news
Free account required • Unsubscribe anytime